Moderna urged Europeans to sign quickly so as not to delay vaccine deliveries. The French Secretary of State for European Affairs assured this Wednesday that the contract between the European Union and the American biotechnology company Moderna for an anti-Covid vaccine is “almost ready” and will be concluded “in the coming days”.
“This contract will exist, it’s a matter of days (…) It is almost ready, Brussels has assured us,” Clément Beaune said on the French continuous news channel LCI.
A “pre-agreement” on the table
The French Secretary of State noted that a “pre-agreement” was already on the table. “The essential parameters of the contract have been there since August 24,” he said, referring to “final details” to be settled.
“Europe will not be late,” he said, recalling that the European Commission was negotiating on behalf of the 27 with laboratories and would fund “very largely” the purchase of vaccines.
“Advanced discussions” had been announced on August 24 between Moderna and the European Commission for the purchase of 80 million doses of the vaccine, but no firm commitment has been signed since. In the meantime, the American biotech has signed with Canada, Japan, Israel, the United Kingdom … Not to mention the 100 million doses promised in early August in the United States. With the EU, “there are plenty of administrative things, files, alignments between countries (…) It is clear that having fallen behind will not limit the total quantity, it will slow down the delivery ”, warned the boss of Moderna.
The Commission has so far signed five contracts to pre-order possible vaccines: with the Swedish-British AstraZenaca, the American Johnson & Johnson, the Franco-British duo Sanofi-GSK, the American-German duo Pfizer / BioNTech and the German CureVac.